FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to new chromone derivatives of general formula,wherein: R1 represents one or more identical or different substitutes on a benzene ring, each of which independently represents a hydrogen atom, or a halogen atom, or C1-4 alkoxy group, or OH group. or group -O(CH2)nO-, wherein n=1 or 2, R2 represents a hydrogen atom, or C1-4 alkyl group； A and B independently represent either a nitrogen atom, or a carbon atom； R3 represents a hydrogen atom or one or more identical or different substitutes specified in a group consisting of: a halogen atom, C1-4 alkyl group, C1-4 alkoxy group, group -O(CH2)nO-, wherein n=1 or 2, group NO2, group NHSO2R4, group NHR5, OH group, C1-4 halogenoalkyl group, CN group, or R3 makes a ring condensed with a benzene ring bearing it, specified in a group consisting of indole, benzimidazole, carbostyril, benzoxazolone and benzoxazolone and benzimidazolone, R4 represents C1-4 alkyl group, or C1-4 dialkylamino group, or C1-4 alkoxyalkyl group, or C1-4 dialkylaminoalkyl group, R5 represents a hydrogen atom, or C1-4 alkylcarbonyl group, or C1-4 alkoxycarbonyl group, and to its pharmaceutically acceptable salts, as well as to methods for preparing them, and to based pharmaceutical compositions, and to using them as a therapeutic agent for central nervous system disorders, as long as they possess the D3 dopaminergic ligand properties.EFFECT: preparing the compositions for treating central nervous system disorders, as long as they possess the D3 dopaminergic ligand properties.17 cl, 1 dwg, 2 tbl, 33 exИзобретение относится к новым производным хромонов общей формулы 1, где: R1 представляет собой один или более чем один из идентичных или различных заместителей на бензольном кольце, каждый из которых независимо представляет собой атом водорода, или атом галогена, или С1-4 алкокси группу, или ОН группу, или группу -O(СН2)nO-, в которой n=1 или 2, R2 представляет собой атом водорода или С1-4 алкильную
